MedTrace Logo

Motus Nova Foot Device for Patients With Hemiplegia

NCT07754773 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2026-08-10

No results posted yet for this study

Summary

Individuals with hemiplegia commonly demonstrate gait deviations such as difficulties with heel strike at initial contact, foot drop in swing, asymmetrical limb loading, muscle activation, and balance impairments. This study evaluates whether a therapeutic device (Motus Nova Foot; FDA approved) used in the home setting can increase heel strike, decrease limp, improve foot clearance in swing phase, improve quality of active muscle contraction of the affected limb, and improve balance. The Motus Nova Foot moves the ankle/foot and uses guided computer/video activities to encourage active participation while automatically recording device use and duration.

Conditions

  • Hemiplegia
  • Cerebral Palsy
  • Hemiplegic Cerebral Palsy

Interventions

DEVICE

Motus Nova Foot

Motus Nova Foot device used in home therapy to improve gait for individuals with hemiplegia.

Sponsors & Collaborators

  • MultiCare Health System Research Institute

    lead OTHER

Principal Investigators

  • Brenna Brandsma, PT, DPT, PCS · MultiCare, Mary Bridge Children's Therapy Research & Movement Lab

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-30
Primary Completion
2027-12-31
Completion
2027-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07754773 on ClinicalTrials.gov